BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland

CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, yesterday announced the opening of a new regional office in Basel, Switzerland. BeiGene has built a European organization, including commercial and clinical teams, and this new location … [Read more…]

GOOD Meat & ADM Partner to Accelerate Cultivated Meat Production

First-of-its-kind partnership highlights how startups can work with established industry leaders to feed the world SAN FRANCISCO & CHICAGO–(BUSINESS WIRE)–Eat Just, Inc., a company that applies cutting-edge science and technology on a mission to create healthier, more sustainable foods, announced today that its GOOD Meat division has entered into a joint development agreement with ADM, … [Read more…]

Deenova Keeps Up its Competitive Streak in France with 2 New Tender Awards at Hazebrouck and Mantes-La-Jolie

MILAN–(BUSINESS WIRE)–Deenova today announced that it continued its last 2 years market dominance in France with another net new RESAH competitive award for its D3 ACCED mechatronic solutions at Centre Hospitalier Hazebrouck near Dunkerque. Separately, Deenova is pleased to simultaneously announce add-on sales of 4 ASTUS cabinets to existing Deenova customer Centre Hospitalier François Quesnay … [Read more…]

Doctor Anywhere Chooses Vonage to Power Telehealth Services in Southeast Asia

SINGAPORE–(BUSINESS WIRE)–Vonage (Nasdaq: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, has been chosen by Doctor Anywhere, a regional omnichannel healthcare company headquartered in Singapore, to deliver timely and effective digital healthcare solutions across Southeast Asia using Vonage’s Video API. Doctor Anywhere – a tech-enabled, omnichannel healthcare service provider – … [Read more…]

ASC Therapeutics Announces Podium and Poster Presentations of IND-Enabling Studies for ASC618, a Second-Generation Gene Therapy for Hemophilia A, at the 25th ASGCT Meeting, May 16-19, 2022 in Washington, D.C.

Podium presentation highlights significant transduction and transgene expression in pharmacokinetic studies in mice, non-human primates and a humanized liver model Poster presentation focuses on pharmacology, toxicology and safety studies Poster presentation focuses on the development of a novel transduction assay to evaluate in-vitro relative Infectivity MILPITAS, Calif.–(BUSINESS WIRE)–#ASCCT22–ASC Therapeutics, a privately held biopharmaceutical company pioneering … [Read more…]

CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

First Study from CANbridge UMass Collaboration Shows Novel Gene Therapy Holds Promise for Spinal Muscular Atrophy Clinical Applications BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced the presentation of the initial data from … [Read more…]

ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine Models for Novel Gene Therapy in Maple Syrup Urine Disease at the 25th ASGCT Meeting

First known bovine model used to demonstrate safety and efficacy in gene replacement therapy MSUD is a severe genetic disease with liver transplantation or dietary restriction as the only treatments currently available MILPITAS, Calif.–(BUSINESS WIRE)–#ASCCT22–ASC Therapeutics in partnership with the University of Massachusetts Medical School (UMMS) and the Clinic for Special Children (CSC), will present … [Read more…]

Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination

SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (Nasdaq: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the previously announced acquisition of Ortho Clinical Diagnostics Holdings plc (“Ortho”) by Quidel and subsequent business combination were approved by Quidel’s stockholders at Quidel’s Special Meeting on May 16, 2022. Subject … [Read more…]

Perimeter Medical Imaging AI to Present at ROTH Canada Showcase Day

TORONTO & DALLAS–(BUSINESS WIRE)–Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced it will participate in investor meetings and host a company presentation at the ROTH Canada Showcase Day to be … [Read more…]

Alight to Participate in J.P. Morgan 50th Annual Global Technology, Media and Communications Conference

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Alight (NYSE: ALIT) (the “Company”) today announced that Chief Executive Officer Stephan Scholl and Chief Financial Officer Katie Rooney will participate in a fireside chat at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference on Tuesday, May 24, 2022 at 11:30 AM ET. Additionally, the Company will participate in one-on-one … [Read more…]